Cargando…
Determining the Potential of DNA Damage Response (DDR) Inhibitors in Cervical Cancer Therapy
SIMPLE SUMMARY: Cervical cancer (CC) is the fourth most common cause of cancer deaths in women. For patients where surgery is not an option, they are treated with cisplatin and radiotherapy (RT) that acts by damaging DNA. However, response is poor, and cisplatin causes kidney injury. The DNA damage...
Autores principales: | Saha, Santu, Rundle, Stuart, Kotsopoulos, Ioannis C., Begbie, Jacob, Howarth, Rachel, Pappworth, Isabel Y., Mukhopadhyay, Asima, Kucukmetin, Ali, Marchbank, Kevin J., Curtin, Nicola |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454916/ https://www.ncbi.nlm.nih.gov/pubmed/36077823 http://dx.doi.org/10.3390/cancers14174288 |
Ejemplares similares
-
DNA Damage Response (DDR) and DNA Repair
por: Vernì, Fiammetta
Publicado: (2022) -
Increased B cell deletion and significantly reduced auto-antibody titre due to premature expression of human complement receptor 2 (CR2, CD21)
por: Pappworth, Isabel Y., et al.
Publicado: (2009) -
Why Human Papillomaviruses Activate the DNA Damage Response (DDR) and How Cellular and Viral Replication Persists in the Presence of DDR Signaling
por: Bristol, Molly L., et al.
Publicado: (2017) -
DDR-mediated crosstalk between DNA-damaged cells and their microenvironment
por: Malaquin, Nicolas, et al.
Publicado: (2015) -
Differences in Durability of PARP Inhibition by Clinically Approved PARP Inhibitors: Implications for Combinations and Scheduling
por: Smith, Hannah L., et al.
Publicado: (2022)